Il Dong Pharmaceutical Co Ltd Asset Resilience Ratio
Il Dong Pharmaceutical Co Ltd asset resilience ratio. Il Dong Pharmaceutical Co Ltd (249420) has an Asset Resilience Ratio of 1.76% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 249420 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Il Dong Pharmaceutical Co Ltd (2016–2024)
Asset resilience ratio of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. This chart shows how Il Dong Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Il Dong Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Il Dong Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Il Dong Pharmaceutical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩10.11 Billion | 1.76% |
| Total Liquid Assets | ₩10.11 Billion | 1.76% |
Asset Resilience Insights
- Limited Liquidity: Il Dong Pharmaceutical Co Ltd maintains only 1.76% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Il Dong Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Il Dong Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Il Dong Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2016–2024)
Il Dong Pharmaceutical Co Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Il Dong Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.14% | ₩12.61 Billion ≈ $8.54 Million |
₩589.04 Billion ≈ $399.19 Million |
-2.44pp |
| 2023-12-31 | 4.58% | ₩28.02 Billion ≈ $18.99 Million |
₩611.26 Billion ≈ $414.24 Million |
+0.53pp |
| 2022-12-31 | 4.06% | ₩26.60 Billion ≈ $18.03 Million |
₩655.81 Billion ≈ $444.43 Million |
+1.36pp |
| 2021-12-31 | 2.69% | ₩19.09 Billion ≈ $12.94 Million |
₩708.97 Billion ≈ $480.46 Million |
+2.59pp |
| 2020-12-31 | 0.10% | ₩600.00 Million ≈ $406.61K |
₩605.28 Billion ≈ $410.19 Million |
-0.08pp |
| 2019-12-31 | 0.18% | ₩1.10 Billion ≈ $748.05K |
₩612.72 Billion ≈ $415.23 Million |
-0.12pp |
| 2018-12-31 | 0.30% | ₩1.70 Billion ≈ $1.15 Million |
₩564.67 Billion ≈ $382.67 Million |
+0.23pp |
| 2017-12-31 | 0.07% | ₩376.06 Million ≈ $254.85K |
₩564.63 Billion ≈ $382.64 Million |
+0.05pp |
| 2016-12-31 | 0.01% | ₩71.17 Million ≈ $48.23K |
₩550.35 Billion ≈ $372.97 Million |
-- |
About Il Dong Pharmaceutical Co Ltd
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central n… Read more